Thoracic Med Onc | Scientist @CUAnschutz | My lab studies the interface between the immune system and lung cancer | Immunotherapy enthusiast | @MayoHemeOnc Alum
Joined August 2019
- Tweets 222
- Following 534
- Followers 623
- Likes 1,070
25 Photos and videos
6 Dec 2024
Thrilled to be part of the Lung TeamLab and the incredible collaboration to eliminate residual disease!
Today we launch the PoweRD 2 Cure ALK Lung Cancer TeamLab!
Uniting researchers from @DanaFarber @MDAndersonNews @kochinstitute @KimmelCancerCtr @MSKCancerCenter @BostonChildrens @MGHCancerCenter @CUCancerCenter @VUMC_Cancer in radical collaboration to target residual lung cancer cells remaining after initial therapy.
Read more: breakthroughcancer.org/2024/โฆ
2
15
1,129
22 May 2024
The promise of immune-based therapies still needs to reach patients with NSCLC bearing driver alterations. We need to look beyond checkpoint inhibitors. Thank you @NarjustFlorezMD and @BiagioRicciutMD
for the amazing discussion! #LCSM
22 May 2024
I hope you are ready for this discussion with Drs. @SchenkLab & @BiagioRicciutMD
I learned SO much only in the first 5 minutes of this conversation about the use of IO in patients with NSCLC and driver mutations.
Including
-Toxicity
-Importance of NGS
-Prognostic and predictive markers
-The impact of tumor microenvironment
Lung Cancer Considered the official @IASLC podcast
โ๏ธ๐๐งฌ๐งซ๐งช
1
3
19
2,731
9 Apr 2024
Donโt miss out! My colleague @TejasPatilMD presenting his exciting work on early MET bypass signaling in ALK and RET driven NSCLC. He is also an @CUCancerCenter Rising Star! @LUNGevity @ALKPositiveinc @RETpositive #LCSM #AACR24
1
6
22
5,694
28 Feb 2024
Thank you to @thehuffproject and @LUNGevity for supporting my career development award. Fantastic experience today sharing with @thehuffproject about the work my lab has been able to do #LCSM #ALKpositve
2
6
33
2,049
28 Feb 2024
@Joshua_Reuss my colleague in arms against lung cancer is doing amazing work to unravel who can benefit from IO/VEGF therapy in his IIT and is supported by @thehuffproject and @LUNGevity. Josh let's talk translation and upping my wall art game ๐
1
235
23 Feb 2024
I am so grateful to have a forever friend that knew me whenโค๏ธ
23 Feb 2024
@MayoHemeOnc gave me a thoracic oncology sister for life!
Dr. @SchenkLab
Fancy breakfast and soulful conversations.
#TTLC24
1
7
1,559
Erin Schenk, MD, PhD retweeted
23 Feb 2024
@MayoHemeOnc gave me a thoracic oncology sister for life!
Dr. @SchenkLab
Fancy breakfast and soulful conversations.
#TTLC24
2
1
6
2,231
14 Dec 2023
One of the best parts of this job is seeing your mentees succeed. Keep up the great work Patrick and Amaie (not pictured but proud to say he got into pharmacy school!). Hearing from both made my day
ALT Patrick at his poster session for CREU 2023
1
21
1,076
13 Nov 2023
Just submitted a large external grant. Because I care about my #worklifebalance, I'm going to give myself 15 hours off before starting on the next grant๐๐คฃ #science #PILife #ButIStillLoveIt
21
1,721
10 Nov 2023
Thank you @ALKPositiveinc! Currently in the lab working towards new plans
9 Nov 2023
ALK #lungcancer patients like having plans A, B and C all lined up. #Research helps us do this.
Ultimately, as Dr Erin Schenk of @SchenkLab says, research helps us do better for our patients not only todayโฆ but tomorrow.
It's really about #MoreResearchMoreLife
#LCAM
1
19
1,175
10 Aug 2023
I often share the words of a mentor/hero of mine (a hematologist) in my clinical practice as a thoracic oncologist:
โIt is better to start the right treatment rather than the fast one.โ
10 Aug 2023
More data showing the importance of *waiting* for NGS results before starting NSCLC therapy whenever possible!
Retrospective analysis @JCOOP_ASCO show that when treatment of driver NSCLC before biomarker results is associated with inferior survival.
ascopubs.org/doi/abs/10.1200โฆ
17
1,290
30 Jun 2023
Thank you for the invitation to speak! One day would love to be part of a session focused on novel immune approaches for EGFR/ALK/ROS1. Cell therapies, BiTEs, macrophage check pointsโฆ
30 Jun 2023
Fascinating lecture describing how the interaction between tumor cells and macrophages in the TME can drive resistance to targeted therapies. Looking forward to future work from @SchenkLab in this space! #DAVAHawaiiLung
2
2
16
2,171
4 May 2023
Amazing fact about science: there are always new and different ways something can go wrong. Luckily our new problem was easily solved. Onward! #labdaydiaries #keepmovingforward
2
372
21 Apr 2023
Highly recommend! The MBCO AACR course was an incredible opportunity to meet with other physician scientists, discuss opportunities and challenges unique to this path. Thank you @christine_lovly for encouraging me to apply
21 Apr 2023
Tagging some of the many amazing people I have met at the @AACR MBCO course: @DrBetofMDPhD @juanosoriomd @BZhangMD @SchenkLab @josephcmurray @catherine_fahey @cnebhan @jmchan88, @JenWargoMD, @carlhjune. Please spread the word about the course! aacr.org/meeting/molecular-bโฆ
2
11
1,725
25 Feb 2023
Goodbye TTLC! It was so nice to see you again #TTLC23
Looking forward to TTLC24!
9
1,024
Erin Schenk, MD, PhD retweeted
24 Feb 2023
Just out!! Congrats to CU Rad Onc and @BK_radiation. CNS downstaging continues to evolve. For pts with extensive brain mets (>30), upfront TKI and deferring WBRT reasonable. See here ๐๐พ sciencedirect.com/science/arโฆ #LCSM @ALKpositiveINT @ALKLungCancer @EGFRResisters @ros1cancer
6
13
843
13 Feb 2023
Congratulations to Schenk Lab Emerita Katie Priest for her work unraveling how an evolving KRAS G12C clone interfered with a ROS1 TKI response.
Thank you to collaborators on Twitter @DLApathologist @rdoebele and @LUNGevity and @ros1cancer for support!
rdcu.be/c5xvH
1
2
12
850
22 Sep 2022
It's 230 pm - a perfect time to write my budget justification jamming to GnR Sweet Child O' Mine
Where do we go?
Where do these costs go?
Where do they go?
6